(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT.

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT.

ST13

US500000088907266

Class

42, 44

Filing

88907266

Registration

7781474

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

05/07/2025

Trademark type

Word

Nice classes

42, 44

Filing date

05/08/2020

Registration date

05/06/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/06/2025

Last transaction

05/07/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

11

Owner location

Victoria, BC, CA

Examiner

CLYBURN, DIONNE

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Aurinia Pharmaceuticals Inc.

Representatives

Matthew R. Wilmot STOEL RIVES LLP

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development of medicinals and pharmaceuticals

Class 44

Medical information servicesproviding health and medical information in the field of diagnostic and treatment of autoimmune disorderskidney disordersopthamalogical disorders and lupus nephritis; conducting medical studies in the field of autoimmune disorderskidney disordersopthamalogical disorders and lupus nephritis; medical evaluation servicesconducting patients studies and functional assessment programs for patients receiving medical therapy services for purposes of guiding treatment and assessment program effectiveness

Publications

History of USPTO decisions and trademark events.

29 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/06/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/06/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/18/2025

PUBO

PUBLISHED FOR OPPOSITION

03/18/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/12/2025

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/27/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/25/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/21/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/21/2025

ALIE

ASSIGNED TO LIE

02/21/2025

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/13/2025

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

11/22/2024

GNSI

INQUIRY TO SUSPENSION E-MAILED

11/22/2024

CNSI

SUSPENSION INQUIRY WRITTEN

11/22/2024

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

01/12/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

07/15/2023

GNSL

LETTER OF SUSPENSION E-MAILED

07/15/2023

CNSL

SUSPENSION LETTER WRITTEN

07/15/2023

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

01/12/2023

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

07/14/2022

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

01/13/2022

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

07/08/2021

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

12/29/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/29/2020

GNSL

LETTER OF SUSPENSION E-MAILED

06/29/2020

CNSL

SUSPENSION LETTER WRITTEN

06/29/2020

DOCK

ASSIGNED TO EXAMINER

06/25/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/20/2020

NWAP

NEW APPLICATION ENTERED

05/12/2020

Continuous trademark protection

Get notified about every new filing that threatens CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT. or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.